607 related articles for article (PubMed ID: 17897683)
1. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
[TBL] [Abstract][Full Text] [Related]
2. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
[TBL] [Abstract][Full Text] [Related]
3. Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.
Tamhane M; Chakilam AR; Jayaraj A; Thakkar V; Taft DR
Drug Dev Ind Pharm; 2010 Mar; 36(3):315-22. PubMed ID: 20170280
[TBL] [Abstract][Full Text] [Related]
4. Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover.
Masereeuw R; Moons MM; Toomey BH; Russel FG; Miller DS
J Pharmacol Exp Ther; 1999 May; 289(2):1104-11. PubMed ID: 10215693
[TBL] [Abstract][Full Text] [Related]
5. Kinetic studies on the competition between famotidine and cimetidine in rats. Evidence of multiple renal secretory systems for organic cations.
Lin JH; Los LE; Ulm EH; Duggan DE
Drug Metab Dispos; 1988; 16(1):52-6. PubMed ID: 2894955
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for the renal secretion of cisplatin.
Nelson JA; Santos G; Herbert BH
Cancer Treat Rep; 1984 Jun; 68(6):849-53. PubMed ID: 6539649
[TBL] [Abstract][Full Text] [Related]
7. Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
Motohashi H; Uwai Y; Hiramoto K; Okuda M; Inui K
Eur J Pharmacol; 2004 Oct; 503(1-3):25-30. PubMed ID: 15496291
[TBL] [Abstract][Full Text] [Related]
8. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
Iwanaga T; Kobayashi D; Hirayama M; Maeda T; Tamai I
Drug Metab Dispos; 2005 Dec; 33(12):1791-5. PubMed ID: 16135657
[TBL] [Abstract][Full Text] [Related]
9. Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney.
Habu Y; Yano I; Okuda M; Fukatsu A; Inui K
Biochem Pharmacol; 2005 Mar; 69(6):993-9. PubMed ID: 15748710
[TBL] [Abstract][Full Text] [Related]
10. Renal secretion of 3'-azido-3'-deoxythymidine by the rat.
Chatton JY; Odone M; Besseghir K; Roch-Ramel F
J Pharmacol Exp Ther; 1990 Oct; 255(1):140-5. PubMed ID: 2213549
[TBL] [Abstract][Full Text] [Related]
11. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
Aiba T; Sakurai Y; Tsukada S; Koizumi T
J Pharmacol Exp Ther; 1995 Jan; 272(1):94-9. PubMed ID: 7815370
[TBL] [Abstract][Full Text] [Related]
12. Effect of 3'-azido-3'-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles.
Griffiths DA; Hall SD; Sokol PP
J Pharmacol Exp Ther; 1992 Jan; 260(1):128-33. PubMed ID: 1530972
[TBL] [Abstract][Full Text] [Related]
13. Interactions between cimetidine, nitrofurantoin, and probenecid active transport into rat milk.
Gerk PM; Oo CY; Paxton EW; Moscow JA; McNamara PJ
J Pharmacol Exp Ther; 2001 Jan; 296(1):175-80. PubMed ID: 11123378
[TBL] [Abstract][Full Text] [Related]
14. Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists.
Tahara H; Kusuhara H; Chida M; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2006 Mar; 316(3):1187-94. PubMed ID: 16291876
[TBL] [Abstract][Full Text] [Related]
15. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
Perri D; Ito S; Rowsell V; Shear NH
Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
[TBL] [Abstract][Full Text] [Related]
16. Postnatal development of organic cation transport and mdr gene expression in mouse kidney.
Dutt A; Priebe TS; Teeter LD; Kuo MT; Nelson JA
J Pharmacol Exp Ther; 1992 Jun; 261(3):1222-30. PubMed ID: 1351097
[TBL] [Abstract][Full Text] [Related]
17. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney.
Muirhead MR; Somogyi AA
Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
19. Renal handling of cisplatin: interactions with organic anions and cations in the dog.
Klein J; Bentur Y; Cheung D; Moselhy G; Koren G
Clin Invest Med; 1991 Oct; 14(5):388-94. PubMed ID: 1742916
[TBL] [Abstract][Full Text] [Related]
20. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
Nadai M; Hasegawa T; Kato K; Wang L; Nabeshima T; Kato N
Drug Metab Dispos; 1993; 21(4):611-6. PubMed ID: 8104119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
